Materias dentro de su búsqueda.
Mostrando 1,441 - 1,460 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.34s Limitar resultados
  1. 1441
    “…Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C virus (HCV) will become a reality in the near future. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
  2. 1442
    “…The hepatitis C virus nonstructural NS5A protein has roles in genome replication, virus assembly, and modulation of host pathways. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Insights into the Complexity and Functionality of Hepatitis C Virus NS5A Phosphorylation
  3. 1443
    “…ABSTRACT: Hepatitis C virus infection leads to liver disease whose severity can range from mild to serious lifelong illness. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Relationship between humoral response against hepatitis C virus and disease overcome
  4. 1444
    “…Recent progress in the understanding of hepatitis C virus (HCV) biology and the availability of in vitro models to study its replication have facilitated the development of direct-acting antiviral agents (DAAs) that target specific steps in the viral replication cycle. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Approaches to hepatitis C treatment and cure using NS5A inhibitors
  5. 1445
    por McAvoy, Norma C., Hayes, Peter C.
    Publicado 2011
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Coffee intake linked to improved SVR in patients undergoing treatment for hepatitis C
  6. 1446
    “…In recent years, clinical research in the field of new treatments for chronic hepatitis C (HCV) has been devoted to developing regimens based on direct-acting antivirals (DAAs), with the goal of increasing treatment efficacy and improving tolerability and safety. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
  7. 1447
    “…BACKGROUND: Patients with chronic hepatitis C (HCV) frequently discontinued dual therapy with pegylated interferon alfa (Peg-IFN) plus ribavirin (RBV) before reaching the recommended duration of 48 or 24 weeks for genotypes (G) 1/4 or 2/3, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    High rates of early treatment discontinuation in hepatitis C-infected US veterans
  8. 1448
    “…BACKGROUND: Adherence is a crucial point for the successful treatment of a hepatitis-C virus infection. Studies have shown that especially adherence to ribavirin is important. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors influencing adherence in Hepatitis-C infected patients: a systematic review
  9. 1449
    “…She had been treated for hepatitis C with telaprevir, ribavirin, and interferon-alpha-2b for 6 months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
  10. 1450
    “…BACKGROUND: Shared injecting apparatus during drug use is the premier risk factor for hepatitis C virus (HCV) transmission. AIMS: To estimate the per-event probability of HCV infection during a sharing event, and the transmission probability of HCV from contaminated injecting apparatus. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment
  11. 1451
    “…Background: Hepatitis C (HCV) is the most common indication for liver transplantation in the US. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
  12. 1452
    “…Determination of an individual's hepatitis C virus (HCV) genotypes prior to antiviral therapy has become increasingly important for the clinical management and prognosis of HCV infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of Hepatitis C Virus Genotypes in District Bannu, Khyber Pakhtunkhwa, Pakistan
  13. 1453
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment of Occult Hepatitis C Virus Infection: Does It Need Special Attention?
  14. 1454
    “…BACKGROUND/AIMS: In Korea, hepatitis C is included as an infectious disease in a sentinel surveillance system. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Regional Distribution of Hepatitis C Virus Infection in the Republic of Korea, 2007–2011
  15. 1455
    “…BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a risk factor for liver diseases such as fibrosis, cirrhosis and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Computational models of liver fibrosis progression for hepatitis C virus chronic infection
  16. 1456
    “…Infection with the hepatitis C virus (HCV) is a major cause of chronic liver diseases and hepatocellular carcinoma worldwide, and thus represents a significant public health problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Interferon Response Gene Signature Is Associated with the Therapeutic Response of Hepatitis C Patients
  17. 1457
    por Huang, He, Kang, Rongyan, Zhao, Zhendong
    Publicado 2014
    “…BACKGROUND AND AIMS: Increasing evidence demonstrates that hepatitis C virus (HCV) infection is associated with atherosclerosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-Analysis
  18. 1458
    “…Recent clinical trials reported an association between DRESS and telaprevir (TVR), an NS3/4A protease inhibitor of chronic hepatitis C (CHC) virus genotype 1. Its diagnosis is challenging given the variable pattern of cutaneous eruption and the myriad internal organ involvement. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS
  19. 1459
    “…She has a history of cirrhosis secondary to chronic hepatitis C (HCV) and was treated with interferon and ribavirin with sustained virological response. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diffuse Hepatic Epithelioid Hemangioendothelioma Developed in a Patient with Hepatitis C Cirrhosis
  20. 1460
    “…BACKGROUND: Hepatitis C Virus (HCV), a public health problem, is an enveloped, single-stranded RNA virus and a member of the Hepacivirus genus of the Flaviviridae family. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serological Assay and Genotyping of Hepatitis C Virus in Infected Patients in Zanjan Province
Herramientas de búsqueda: RSS